Trial Profile
A phase II study of docetaxel (taxotere) (NSC#628503) in children with recurrent solid tumors
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 04 Sep 2005 New trial record.